Showing results (1-10 of 621) with videos related to
Sort By:
Pageof 63
CNS Drugs|May 26, 2018
Correction to: Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010Simon Faissner, Ralf GoldCNS Drugs|July 22, 2022
Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future DevelopmentsSimon Faissner, Ralf GoldFortschritte Der Neurologie-Psychiatrie|November 30, 2019
[New therapeutic approaches in progressive multiple sclerosis]Simon Faissner, Ralf GoldCold Spring Harbor Perspectives in Medicine|March 4, 2018
Oral Therapies for Multiple SclerosisSimon Faissner, Ralf GoldTherapeutic Advances in Neurological Disorders|October 11, 2019
Progressive multiple sclerosis: latest therapeutic developments and future directionsSimon Faissner, Ralf GoldCNS Drugs|March 31, 2018
Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010Simon Faissner, Ralf GoldNeurology(R) Neuroimmunology & Neuroinflammation|May 24, 2019
Antineuroinflammatory drugs in HIV-associated neurocognitive disorders as potential therapyBjörn Ambrosius, Ralf Gold, Andrew Chan, et al.Annals of Clinical and Translational Neurology|January 12, 2026
Effects of Biological Sex and Age on Cerebrospinal Fluid Markers-A Retrospective Observational StudyIsabel-Sophie Hafer, Simon Faissner, Ralf Gold, et al.Nature Reviews. Drug Discovery|August 11, 2019
Progressive multiple sclerosis: from pathophysiology to therapeutic strategiesSimon Faissner, Jason R Plemel, Ralf Gold, et al.Journal of Central Nervous System Disease|May 24, 2014
Efficacy and side effects of natalizumab therapy in patients with multiple sclerosisRobert Hoepner, Simon Faissner, Anke Salmen, et al.Pageof 63